Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Seborrheic Dermatitis

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    24 result(s) found for: Seborrheic Dermatitis. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2008-005217-22 Sponsor Protocol Number: RD.03.SPR.29079 Start Date*: 2009-03-04
    Sponsor Name:Galderma Research & Development
    Full Title: Efficacy and Safety of Clobetasol propionate shampoo 0.05% used in association with an antifungal shampoo in the treatment of moderate to severe Scalp Seborrheic Dermatitis
    Medical condition: moderate to severe Scalp Seborrheic Dermatitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039788 Seborrheic dermatitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2017-003106-41 Sponsor Protocol Number: CHDR1733 Start Date*: 2018-09-05
    Sponsor Name:Maruho Co., Ltd.
    Full Title: A phase 2, randomized, vehicle and ketoconazole-controlled, evaluator-blinded, study to explore the efficacy, pharmacodynamics and safety of omiganan 1.75% topical gel BID in patients with mild to ...
    Medical condition: Mild to moderate facial seborrheic dermatitis.
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004858 10039788 Seborrheic dermatitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-008353-35 Sponsor Protocol Number: DC0115GM2012A Start Date*: 2009-03-18
    Sponsor Name:PIERRE FABRE DERMATOLOGIE REPRESENTED BY INSTITUT DE RECHERCHE PIERRE FABRE
    Full Title: EFFICACY STUDY OF A CICLOPIROXOLAMINE 1% FOAM (DC115 GM 02A) VERSUS CICLOPIROXOLAMINE 1.5% SHAMPOO (SEBIPROX®) IN THE TREATMENT OF MODERATE SEBORRHEIC DERMATITIS OF THE SCALP
    Medical condition: Topical treatment of moderate seborrheic dermatitis of the scalp
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039788 Seborrheic dermatitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2006-002060-26 Sponsor Protocol Number: 1401201 Start Date*: 2006-12-04
    Sponsor Name:Intendis GmbH
    Full Title: A double-blind, randomized, vehicle-controlled, 6-week exploratory multicenter pilot study of the efficacy and safety of Azelaic Acid (AzA) 15% gel in the topical treatment of mild to moderate seb...
    Medical condition: Patients with mild to moderate seborrheic dermatitis of the facial area and meeting the specific eligibility criteria
    Disease: Version SOC Term Classification Code Term Level
    8.1 10012488 Dermatitis seborrheic LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2020-000720-19 Sponsor Protocol Number: IDI01/2020 Start Date*: 2020-07-22
    Sponsor Name:IDI FARMACEUTICI SRL
    Full Title: A prospective, randomized, multicenter, open- label, two-arm and parallel-group Study to evaluate the efficacy and safety of Nicotinamide DS compared to Ciclopirox olamine cream at 1% in patients a...
    Medical condition: Patients affected by seborrheic dermatitis.
    Disease: Version SOC Term Classification Code Term Level
    21.1 10040785 - Skin and subcutaneous tissue disorders 10039793 Seborrhoeic dermatitis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-003984-30 Sponsor Protocol Number: CASM981N2203S Start Date*: 2006-11-22
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A multicenter, randomized, double-blind, two-arm, vehicle-controlled, parallel-group, two stage study to evaluate and demonstrate the efficacy and to evaluate the safety of pimecrolimus 1% cream in...
    Medical condition: Seborrhoeic Dermatitis (SD)
    Disease: Version SOC Term Classification Code Term Level
    8.1 10039793 Seborrhoeic dermatitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-000292-15 Sponsor Protocol Number: S241-GB-10 Start Date*: 2006-03-13
    Sponsor Name:Stiefel Laboratories Maidenhead Ltd.
    Full Title: A Phase II, Single-Centre, Randomised,Double-Blind, Parallel Group, CPO Solution, Dose Range Finding Study in Subjects with Seborrhoeic Dermatitis of the Scalp
    Medical condition: Seborrhoeic dermatitis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10039793 Seborrhoeic dermatitis LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-001371-35 Sponsor Protocol Number: S241-GB-03 Start Date*: 2005-05-18
    Sponsor Name:Stiefel Laboratories Maidenhead Ltd (commonly known as Stiefel Laboratories International Division)
    Full Title: A Double-Blind, Placebo Controlled, Half-Head Design, CPO Solution Dose Ranging-Finding Study in Patients with Seborrhoeic Dermatitis of the Scalp
    Medical condition: Seborrhoeic dermatitis
    Disease: Version SOC Term Classification Code Term Level
    8.0 10039793 LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-013120-23 Sponsor Protocol Number: 200802.2.45 Start Date*: 2009-09-11
    Sponsor Name:LABCATAL
    Full Title: Efficacité et tolérance du LBC 45 dans la dermite séborrhéique du cuir chevelu
    Medical condition: Dermite séborrhéique du cuir chevelu
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039788 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-022861-93 Sponsor Protocol Number: 201003.2.45 Start Date*: 2010-10-28
    Sponsor Name:Laboratoire LABCATAL
    Full Title: Confirmation de l'efficacité et de la tolérance du LBC 45 dans la dermite séborrhéique du cuir chevelu
    Medical condition: Dermite séborrhéique du cuir chevelu
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039788 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-000984-34 Sponsor Protocol Number: 6630-9170-917016 Start Date*: 2018-05-24
    Sponsor Name:Medice Arzneimittel Pütter GmbH & Co KG
    Full Title: A multi-center, randomized, double-blind, phase II trial with intraindividual comparison to assess superiority of Soventol HydroCortisonACETAT 1 % Cremogel versus vehicle on lesional skin in patien...
    Medical condition: atopic dermatitis, seborrheic eczema or stasis dermatitis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10040785 - Skin and subcutaneous tissue disorders 10003639 Atopic dermatitis LLT
    20.0 10040785 - Skin and subcutaneous tissue disorders 10062813 Seborrheic eczema LLT
    20.0 10040785 - Skin and subcutaneous tissue disorders 10041955 Stasis dermatitis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2013-000715-25 Sponsor Protocol Number: 6520-9170-07 Start Date*: 2013-07-23
    Sponsor Name:MEDICE Arzneimittel Pütter GmbH & Co.KG
    Full Title: A multi-center, randomized, double-blind, phase II trial with intraindividual comparison to assess superiority of Soventol HydroCort 1% cream versus vehicle on lesional skin in patients with mild a...
    Medical condition: manifest atopic dermatitis diagnosed according to Hanifin and Rajka, or seborrheic eczema or stasis dermatitis
    Disease: Version SOC Term Classification Code Term Level
    14.1 10040785 - Skin and subcutaneous tissue disorders 10041955 Stasis dermatitis PT
    14.1 10040785 - Skin and subcutaneous tissue disorders 10062813 Seborrheic eczema LLT
    14.1 10040785 - Skin and subcutaneous tissue disorders 10003641 Atopic eczema LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2007-004649-14 Sponsor Protocol Number: ASF-1057-303 Start Date*: 2008-02-19
    Sponsor Name:Astion Pharma A/S
    Full Title: Safety of ASF 1057 cream 0.5% under long term use in the treatment of seborrhoeic dermatitis: A 12 month open label extension multi-centre phase III trial
    Medical condition: Seborrhoeic dermatitis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing) FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-006208-21 Sponsor Protocol Number: ELKE-2006 Start Date*: 2006-10-23
    Sponsor Name:Department of Dermatology, University of Kiel
    Full Title: Clinical Efficacy of Pimecrolimus Cream in Seborrheic Dermatitis. Efficacy of pimecrolimus in normalizing clinical symptoms, explorative study of barrier function, hydration, lipid content and diff...
    Medical condition: Efficacy of pimecrolimus in normalizing clinical symptoms, explorative study of barrier function, hydration, lipid content and differentiation in seborrheic dermatitis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-001175-38 Sponsor Protocol Number: 6520-9170-08 Start Date*: 2012-01-13
    Sponsor Name:MEDICE Arzneimittel Pütter GmbH & CO.KG
    Full Title: A multi-center, randomized, double-blind,phase II trial with intraindividual comparison to assess superiority of Soventol HydroCort 0.5 % Cremogel vs vehicle on lesional skin in patients with mild ...
    Medical condition: manifest atopic dermatitis diagnosed according to Hanifin and Rajka, or seborrheic eczema or stasis dermatitis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2007-006188-59 Sponsor Protocol Number: K301-1 Start Date*: 2008-01-14
    Sponsor Name:Moberg Derma AB
    Full Title: A multicenter, randomised double blind, placebo-controlled study of efficacy, safety and tolerability of Kaprolac® K301 for the treatment of seborrhoeic eczema (SE) of the scalp.
    Medical condition: seborrhoeic dermatitis of the scalp
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039794 Seborrhoeic dermatitis capitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2006-005242-36 Sponsor Protocol Number: K40-3 Start Date*: 2006-12-13
    Sponsor Name:Moberg Derma AB
    Full Title: A multicenter, randomised, double-blind, placebo-controlled clinical study evaluating efficacy, safety and tolerability of topical K40 in 8 weeks treatment of adult patients with moderate to severe...
    Medical condition: Seborrhoeic Dermatitis of the scalp.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10039794 Seborrhoeic dermatitis capitis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2011-000852-40 Sponsor Protocol Number: TBSH-01 Start Date*: 2012-08-03
    Sponsor Name:Dermal Laboratories
    Full Title: A double-blind, placebo-controlled study determining the efficacy of terbinafine shampoo in the treatment of pityriasis capitis and seborrhoeic dermatitis.
    Medical condition: The two severe dandruff conditions to be investigated in this study are pityriasis capitis and seborrhoeic dermatitis.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10040785 - Skin and subcutaneous tissue disorders 10011859 Dandruff PT
    14.1 10040785 - Skin and subcutaneous tissue disorders 10039794 Seborrhoeic dermatitis capitis LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2004-004275-11 Sponsor Protocol Number: CASM981M2308 Start Date*: 2005-03-25
    Sponsor Name:Novartis Pharma Services AG
    Full Title: An open-label study to investigate blood concentrations, safety, tolerability and efficacy of Elidel® Cream 1% in patients with moderate or severe seborrheic dermatitis treated topically for 3 weeks.
    Medical condition: Seborrheic dermatitis
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2017-000610-26 Sponsor Protocol Number: MK-4117-202 Start Date*: 2017-02-09
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
    Full Title: A Phase III, Multicenter, Open-Label Long-Term Trial to Study the Efficacy and Safety of MK-4117 in Japanese Subjects With Eczema/Dermatitis and Dermal Pruritus.
    Medical condition: Eczema/dermatitis and the dermal pruritus (itchy skin disease)
    Disease: Version SOC Term Classification Code Term Level
    19.1 10040785 - Skin and subcutaneous tissue disorders 10012431 Dermatitis PT
    19.1 10040785 - Skin and subcutaneous tissue disorders 10014184 Eczema PT
    19.1 10040785 - Skin and subcutaneous tissue disorders 10037090 Pruritus cutaneous LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 19 21:11:46 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA